These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7515974)

  • 21. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection.
    Borrego B; Novella IS; Giralt E; Andreu D; Domingo E
    J Virol; 1993 Oct; 67(10):6071-9. PubMed ID: 7690417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Foot-and-mouth disease and its antigens.
    Bachrach HL
    Adv Exp Med Biol; 1985; 185():27-46. PubMed ID: 2416203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites.
    Kitson JD; McCahon D; Belsham GJ
    Virology; 1990 Nov; 179(1):26-34. PubMed ID: 1699353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amino acid changes outside the G-H loop of capsid protein VP1 of type O foot-and-mouth disease virus confer resistance to neutralization by antipeptide G-H serum.
    Krebs O; Ahl R; Straub OC; Marquardt O
    Vaccine; 1993; 11(3):359-62. PubMed ID: 7680514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection.
    Wong HT; Cheng SC; Chan EW; Sheng ZT; Yan WY; Zheng ZX; Xie Y
    Virology; 2000 Dec; 278(1):27-35. PubMed ID: 11112477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
    Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.
    Stave JW; Card JL; Morgan DO
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Model of the equine rhinitis A virus capsid: identification of a major neutralizing immunogenic site.
    Kriegshäuser G; Wutz G; Lea S; Stuart D; Skern T; Kuechler E
    J Gen Virol; 2003 Sep; 84(Pt 9):2365-2373. PubMed ID: 12917457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of yellow fever virus proteins E and NS1 expressed in Vero and Spodoptera frugiperda cells.
    Desprès P; Girard M; Bouloy M
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1331-42. PubMed ID: 1710649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The structure and antigenicity of a type C foot-and-mouth disease virus.
    Lea S; Hernández J; Blakemore W; Brocchi E; Curry S; Domingo E; Fry E; Abu-Ghazaleh R; King A; Newman J
    Structure; 1994 Feb; 2(2):123-39. PubMed ID: 8081743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative studies of the capsid precursor polypeptide P1 and the capsid protein VP1 cDNA vectors for DNA vaccination against foot-and-mouth disease virus.
    Yang NS; Wang JH; Lin KF; Wang CY; Kim SA; Yang YL; Jong MH; Kuo TY; Lai SS; Cheng RH; Chan MT; Liang SM
    J Gene Med; 2005 Jun; 7(6):708-17. PubMed ID: 15693054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in Spain.
    González M; Mateu MG; Martínez MA; Carrillo C; Sobrino F
    Vaccine; 1992; 10(11):731-4. PubMed ID: 1279905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection conferred by TrpE fusion proteins containing portions of the C-terminal region of capsid protein VP1 of foot-and-mouth disease virus.
    Giavedoni LD; Kaplan G; Marcovecchio F; Piccone ME; Palma EL
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():967-71. PubMed ID: 1849980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.
    Mateu MG; Hernández J; Martínez MA; Feigelstock D; Lea S; Pérez JJ; Giralt E; Stuart D; Palma EL; Domingo E
    J Virol; 1994 Mar; 68(3):1407-17. PubMed ID: 8107204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigenic variation among foot-and-mouth disease virus type A field isolates of 1997-1999 from Iran.
    Marquardt O; Freiberg B
    Vet Microbiol; 2000 Jun; 74(4):377-86. PubMed ID: 10831859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of virus neutralizing epitopes on naturally occurring variants of type A12 foot-and-mouth disease virus.
    Moore DM; Vakharia VN; Morgan DO
    Virus Res; 1989 Dec; 14(4):281-95. PubMed ID: 2483013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs.
    Sanz-Parra A; Jimenez-Clavero MA; García-Briones MM; Blanco E; Sobrino F; Ley V
    Virology; 1999 Jun; 259(1):129-34. PubMed ID: 10364496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants.
    Stave JW; Card JL; Morgan DO; Vakharia VN
    Virology; 1988 Jan; 162(1):21-9. PubMed ID: 2827379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modified-live infectious bovine rhinotracheitis virus (IBRV) vaccine expressing foot-and-mouth disease virus (FMDV) capsid protein epitopes on surface of hybrid virus particles.
    Kit S; Kit M; DiMarchi R; Little S; Gale C
    Adv Exp Med Biol; 1991; 303():211-20. PubMed ID: 1725233
    [No Abstract]   [Full Text] [Related]  

  • 40. A 10-amino-acid linear sequence of VP1 of foot and mouth disease virus containing B- and T-cell epitopes induces protection in mice.
    Zamorano P; Wigdorovitz A; Perez-Filgueira M; Carrillo C; Escribano JM; Sadir AM; Borca MV
    Virology; 1995 Oct; 212(2):614-21. PubMed ID: 7571431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.